Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Improving bowel preparation for colonoscopy in people with IBD

Official title: Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients: A National Multicenter Prospective Study

Run by Changhai Hospital · NCT07335705 · Data updated 2026-11-12

This project will test whether current bowel-prep practices and individual patient factors affect how clean the bowel is for people with IBD having a colonoscopy.

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment1000 (estimated)
SponsorChanghai Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedDecember 8, 2025
Main results expectedOctober 1, 2026
Study endsOctober 1, 2026
Registry record updatedMay 14, 2026
Trial IDNCT07335705 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18 years and older) with a diagnosis of IBD per the 2023 guidelines who are scheduled for colonoscopy and can provide informed consent are ideal candidates.

Probably not a fit

Patients with recent major myocardial infarction, severe cardiac/hepatic/renal failure, active anticoagulant use or coagulation disorders, pregnancy or lactation, recent acute intestinal infection, colorectal tumors or obstruction, or severe cognitive or hearing impairment are excluded and unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Patients scheduled for colonoscopy at participating hospitals will be approached before the procedure or within seven days after their colonoscopy to give informed consent and complete a detailed questionnaire. The questionnaire records patient factors (eg, BMI, surgery history, diabetes, bowel habits) and specifics of the bowel-preparation protocol (diet, cleansing agent, dose, timing, and interval before colonoscopy). Clinicians will record Boston Bowel Preparation Scale scores for each segment and collect colonoscopy diagnoses and endoscopic activity scores. Data will be used to describe current protocol implementation since the 2023 guidelines, identify risk factors for poor preparation, and develop a prediction model to guide personalized regimens.

Why it matters

Potential benefit: If successful, this work could enable personalized bowel-prep plans that produce cleaner colons, reduce repeat procedures, and improve diagnostic accuracy for people with IBD.

How similar studies have gone: Prior work in general colonoscopy populations has identified risk factors and produced prediction tools for poor bowel prep, but IBD-specific, post-2023-guideline data and validated models remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 years or older, of any gender, scheduled for colonoscopy;
* Patients diagnosed with Inflammatory Bowel Disease (IBD) according to the 2023 edition of the Guidelines for the Diagnosis and Treatment of Inflammatory Bowel Disease;
* Voluntary participation in this study and provision of signed informed consent.

Exclusion Criteria:

* History of acute myocardial infarction (within the past 6 months), severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders;
* Current use of anticoagulants (e.g., aspirin, warfarin) or presence of coagulation disorders;
* Pregnant or lactating women;
* Acute intestinal infection within the past 2 weeks;
* History of colorectal tumors, familial adenomatous polyposis, or Peutz-Jeghers syndrome;
* History of intestinal obstruction, perforation, stenosis, or any other condition preventing completion of the examination;
* Severe hearing impairment, cognitive dysfunction, or inability to cooperate with the survey;
* Individuals already enrolled in this study who schedule a repeat colonoscopy;
* Currently participating in another clinical observational trial or having participated in any other clinical trial within the past 60 days;
* Refusal to sign the written informed consent form.

Where it's running

  • Changhai Hospital
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.